rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-12-17
|
pubmed:abstractText |
To determine the safety, efficacy, and PK profile of intravenous busulfan (Bu) in the context of a Bu and cyclophosphamide (IVBuCy) preparative regimen in children undergoing allogeneic hematopoietic stem cell transplantation (HSCT).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1545-5017
|
pubmed:author |
pubmed-author:ChanKa WahKW,
pubmed-author:HayashiRobert JRJ,
pubmed-author:KadotaRichardR,
pubmed-author:KletzelMorrisM,
pubmed-author:MezziKhaledK,
pubmed-author:NiederMichael LML,
pubmed-author:Pediatric Blood, Marrow Transplant Consortium,
pubmed-author:PrzepiorkaDonnaD,
pubmed-author:WallDonna ADA,
pubmed-author:YeagerAndrew MAM
|
pubmed:copyrightInfo |
(c) 2009 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
291-8
|
pubmed:meshHeading |
pubmed-meshheading:19743300-Adolescent,
pubmed-meshheading:19743300-Area Under Curve,
pubmed-meshheading:19743300-Busulfan,
pubmed-meshheading:19743300-Child,
pubmed-meshheading:19743300-Child, Preschool,
pubmed-meshheading:19743300-Dose-Response Relationship, Drug,
pubmed-meshheading:19743300-Drug Toxicity,
pubmed-meshheading:19743300-Female,
pubmed-meshheading:19743300-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:19743300-Hepatic Veno-Occlusive Disease,
pubmed-meshheading:19743300-Humans,
pubmed-meshheading:19743300-Infant,
pubmed-meshheading:19743300-Infusions, Intravenous,
pubmed-meshheading:19743300-Male,
pubmed-meshheading:19743300-Metabolic Clearance Rate,
pubmed-meshheading:19743300-Myeloablative Agonists,
pubmed-meshheading:19743300-Prospective Studies,
pubmed-meshheading:19743300-Survival Analysis,
pubmed-meshheading:19743300-Transplantation, Homologous
|
pubmed:year |
2010
|
pubmed:articleTitle |
Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation.
|
pubmed:affiliation |
Cardinal Glennon Children's Hospital/Saint Louis University, St. Louis, Missouri, USA. donna.wall@cancercare.mb.ca
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|